Randomized clinical trial of preoperative intranasal mupirocin to reduce surgical-site infection after digestive surgery

British Journal of Surgery

Volumn 90, Issue 9, 2003, Pages 1072-1075

  Suzuki, Y ^a   Kamigaki, T ^a   Fujino, Y ^a   Tominaga, M ^a   Ku, Y ^a   Kuroda, Y ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PSEUDOMONIC ACID;

ABDOMINAL SURGERY; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPUTUM CULTURE; SURGICAL INFECTION; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DIGESTIVE SYSTEM DISEASES; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; MUPIROCIN; OINTMENTS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION;

EID: 0141629396     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4269     Document Type: Article

References (13)

1. Dellinger EP. Surgical infections and choice of antibiotics. In Sabiston Textbook of Surgery. The Biological Basis of Modern Surgical Practice (16th edn), Townsend CM Jr, Beauchamp RD, Evers BM, Mattox KL (eds). W. B. Saunders: Philadelphia, 2001; 171-188.
2. Williams REO, Jevons MP, Shooter RA, Hunter CJW, Girling JA, Griffiths JD et al. Nasal staphylococci and sepsis in hospital patients. BMJ 1959; ii: 658-662.
3. Weinstein HJ. The relation between the nasal-staphylococcal-carrier state and the incidence of postoperative complications. N Engl J Med 1959; 260: 1303-1308.
4. Kluytymans JAJW, Mouton JW, Ijzerman EPF, Vandenbroucke-Grauls CMJE, Maat AWPM, Wagenvoort JHT et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis 1995; 171: 216-219.
5. Cimochowski GE, Harostock MD, Brown R, Bernardi M, Alonzo N, Coyle K. Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann Thorac Surg 2001; 71: 1572-1579.
6. Harrower HW. Isolation of incisions into body cavities. Am J Surg 1968; 116: 824-826.
7. Psaila JV, Wheeler MH, Crosby DL. The role of plastic wound drapes in the prevention of wound infection following abdominal surgery. Br J Surg 1977; 64: 729-732.
8. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999; 20: 252-278.
9. Bertino JS Jr. Intranasal mupirocin for outbreaks of methicillin-resistant Staphylococcus aureus. Am J Health Syst Pharm 1997; 54: 2185-2191.
10. Kaye ET, Kaye KM. Topical antibacterial agents. Infect Dis Clin North Am 1995; 9: 547-559.
11. Caderna JE, Terpenning MS, Ensberg M, Bradley SF, Kauffman CA. Staphylococcus aureus nasal colonization in a nursing home: eradication with mupirocin. Infect Control Hosp Epidemiol 1990; 11: 13-16.
12. Dacre J, Emmerson AM, Jenner EA. Gentamicin methicillin-resistant Staphylococcus aureus: epidemiology and containment of an outbreak. J Hosp Infect 1986; 7: 130-136.
13. Crabtree JH, Hadnott LL, Burchette RJ, Siddiqi RA. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Adv Perit Dial 2000; 16: 271-275.